FMR LLC
FMR LLC
FMR LLC insider trades: Beam Therapeutics (BEAM) stock buys and sales
Beam Therapeutics Last trade Jun 26, 2026 166 Form 4 filings
$10.0M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
126
Open-market trades
since 2009
39
Companies
last trade 2026
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where FMR LLC reports to the SEC
GPCRStructure Therapeutics
Insider · last filing Jul 24, 2026
No market trades
BEAMBeam Therapeutics
Insider · last filing Jun 29, 2026
-$40.8M
AVLNAvalyn Pharma
Insider · last filing May 5, 2026
No market trades
MTSRMetsera
Insider · last filing Nov 17, 2025
-$21K
SANASana Biotechnology
Insider · last filing Jan 10, 2025
-$1.9M
BCAXBicara Therapeutics
Insider · last filing Sep 18, 2024
No market trades
and 33 more companies
Open-market buys and sales
126 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | BEAM | ↓ Sell | 284,860 | $35.24 | $10.0M | F-Prime Capital Partners Healthcare Fund | Jun 29, 2026 (3d) |
| Nov 3, 2025 | MTSR | ↓ Sell | 193 | $61.23 | $12K | Impresa Fund IV LLC | Nov 5, 2025 (2d) |
| Oct 27, 2025 | BEAM | ↓ Sell | 459 | $26.68 | $12K | FMR Capital, Inc. | Oct 29, 2025 (2d) |
| Sep 2, 2025 | MTSR | ↓ Sell | 268 | $36.00 | $10K | Impresa Fund IV LLC | Sep 4, 2025 (2d) |
| Jul 30, 2025 | BEAM | ↓ Sell | 48,374 | $20.50 | $992K | Shares held by persons and entities whos | Aug 1, 2025 (2d) |
| Jan 8, 2025 | SANA | ↓ Sell | 290,912 | $6.49 | $1.9M | F-Prime Capital Partners Life Sciences F | Jan 10, 2025 (2d) |
| Feb 14, 2024 | BEAM | ↓ Sell | 900,000 | $30.55 | $27.5M | F-Prime Capital Partners Healthcare Fund | Feb 15, 2024 (1d) |
| Feb 13, 2024 | BEAM | ↓ Sell | 1,565 | $30.76 | $48K | Shares held by persons and entities whos | Feb 15, 2024 (2d) |
| Nov 29, 2023 | NONE | ↑ Buy | 391 | $25.54 | $10K | FMR Capital Inc. | Nov 29, 2023 (0d) |
| Nov 29, 2023 | NONE | ↑ Buy | 391 | $25.54 | $10K | FMR Capital Inc. | Nov 29, 2023 (0d) |
| Jun 27, 2023 | NONE | ↑ Buy | 346,723 | $25.23 | $8.7M | Fidelity Multi-Strategy Credit Fund | Jun 29, 2023 (2d) |
| Sep 6, 2022 | BEAM | ↓ Sell | 551 | $54.25 | $30K | F-Prime Inc. | Sep 8, 2022 (2d) |
| Aug 5, 2022 | BEAM | ↓ Sell | 20,159 | $60.50 | $1.2M | F-Prime Inc. | Aug 8, 2022 (3d) |
| Aug 5, 2022 | BEAM | ↓ Sell | 167 | $61.00 | $10K | Impresa Fund III Limited Partnership | Aug 8, 2022 (3d) |
| Jul 12, 2022 | VERV | ↓ Sell | 163,000 | $20.78 | $3.4M | F-Prime Capital Partners Healthcare Fund | Jul 14, 2022 (2d) |
| Jul 1, 2022 | VERV | ↓ Sell | 38,775 | $15.66 | $607K | F-Prime Capital Partners Healthcare Fund | Jul 6, 2022 (5d) |
| Jun 30, 2022 | VERV | ↓ Sell | 53,219 | $15.45 | $822K | F-Prime Capital Partners Healthcare Fund | Jul 1, 2022 (1d) |
| Apr 13, 2022 | BEAM | ↓ Sell | 18,803 | $50.39 | $948K | F-Prime Inc. | Apr 14, 2022 (1d) |
| Apr 13, 2022 | BEAM | ↓ Sell | 663 | $50.75 | $34K | Impresa Fund III Limited Partnership | Apr 14, 2022 (1d) |
| Mar 9, 2022 | VERV | ↓ Sell | 3,971 | $29.01 | $115K | F-Prime Capital Partners Healthcare Fund | Mar 11, 2022 (2d) |
| Feb 9, 2022 | VERV | ↓ Sell | 13,190 | $29.46 | $389K | F-Prime Capital Partners Healthcare Fund | Feb 11, 2022 (2d) |
| Feb 1, 2022 | VERV | ↓ Sell | 35,574 | $29.04 | $1.0M | F-Prime Capital Partners Healthcare Fund | Feb 3, 2022 (2d) |
| Jan 27, 2022 | VERV | ↓ Sell | 158,836 | $31.12 | $4.9M | F-Prime Capital Partners Healthcare Fund | Jan 28, 2022 (1d) |
| Feb 5, 2021 | ORTX | ↓ Sell | 2,045,510 | $6.98 | $14.3M | By F-Prime Capital Partners Healthcare F | Feb 10, 2021 (5d) |
| Jan 2, 2020 | ORTX | ↓ Sell | 28,474 | $13.46 | $383K | By F-Prime Capital Partners Healthcare F | Jan 6, 2020 (4d) |
| Apr 1, 2019 | DTIL | ↑ Buy | 50,000 | $16.00 | $800K | By F-Prime Capital Partners Healthcare F | Apr 3, 2019 (2d) |
| Aug 8, 2018 | VRAY | ↓ Sell | 200,000 | $10.02 | $2.0M | F-Prime Capital Partners Healthcare Fund | Aug 10, 2018 (2d) |
| Aug 7, 2018 | VRAY | ↓ Sell | 173,929 | $10.48 | $1.8M | F-Prime Capital Partners Healthcare Fund | Aug 8, 2018 (1d) |
| Aug 3, 2018 | VRAY | ↓ Sell | 334,675 | $11.44 | $3.8M | F-Prime Capital Partners Healthcare Fund | Aug 6, 2018 (3d) |
| Aug 1, 2018 | VRAY | ↓ Sell | 127,206 | $12.07 | $1.5M | F-Prime Capital Partners Healthcare Fund | Aug 2, 2018 (1d) |
| Jul 30, 2018 | VRAY | ↓ Sell | 258,565 | $11.51 | $3.0M | F-Prime Capital Partners Healthcare Fund | Jul 31, 2018 (1d) |
| Jul 26, 2018 | VRAY | ↓ Sell | 295,850 | $12.08 | $3.6M | F-Prime Capital Partners Healthcare Fund | Jul 27, 2018 (1d) |
| Apr 3, 2018 | UMRX | ↑ Buy | 94,052 | $12.00 | $1.1M | F-Prime Capital Partners Healthcare Fund | Apr 5, 2018 (2d) |
| Apr 25, 2017 | VRAY | ↓ Sell | 106,781 | $6.76 | $722K | Indirect | Apr 27, 2017 (2d) |
| Apr 24, 2017 | VRAY | ↓ Sell | 101,139 | $6.71 | $678K | Indirect | Apr 25, 2017 (1d) |
| Apr 20, 2017 | VRAY | ↓ Sell | 101,236 | $6.90 | $698K | Indirect | Apr 21, 2017 (1d) |
| Apr 18, 2017 | VRAY | ↓ Sell | 107,217 | $7.24 | $776K | Indirect | Apr 19, 2017 (1d) |
| Apr 13, 2017 | VRAY | ↓ Sell | 115,860 | $7.44 | $862K | Indirect | Apr 17, 2017 (4d) |
| Apr 12, 2017 | VRAY | ↓ Sell | 179,494 | $7.40 | $1.3M | Indirect | Apr 13, 2017 (1d) |
| Apr 10, 2017 | VRAY | ↓ Sell | 178,556 | $7.77 | $1.4M | Indirect | Apr 11, 2017 (1d) |
| Apr 7, 2017 | VRAY | ↓ Sell | 52,050 | $7.89 | $411K | Indirect | Apr 10, 2017 (3d) |
| Apr 5, 2017 | VRAY | ↓ Sell | 196,397 | $7.90 | $1.6M | Indirect | Apr 6, 2017 (1d) |
| Apr 3, 2017 | VRAY | ↓ Sell | 217,883 | $8.29 | $1.8M | Indirect | Apr 4, 2017 (1d) |
| Mar 30, 2017 | VRAY | ↓ Sell | 28,661 | $8.46 | $242K | Indirect | Apr 3, 2017 (4d) |
| Mar 13, 2017 | PTI | ↓ Sell | 25,000 | $12.94 | $324K | Indirect | Mar 15, 2017 (2d) |
| Mar 10, 2017 | PTI | ↓ Sell | 25,000 | $12.04 | $301K | Indirect | Mar 13, 2017 (3d) |
| Mar 9, 2017 | PTI | ↓ Sell | 29,300 | $12.08 | $354K | Indirect | Mar 10, 2017 (1d) |
| Mar 7, 2017 | PTI | ↓ Sell | 60,000 | $13.01 | $781K | Indirect | Mar 8, 2017 (1d) |
| Mar 3, 2017 | PTI | ↓ Sell | 45,000 | $13.91 | $626K | Indirect | Mar 6, 2017 (3d) |
| Mar 1, 2017 | PTI | ↓ Sell | 45,000 | $14.62 | $658K | Indirect | Mar 2, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BEAM insiders
Open-market trades in the last 12 months
John M. Evans
CEO
5 sales
Oct 16, 2026
Bethany J Cavanagh
SVP, Finance and Treasurer
3 sales
Oct 1, 2026
Giuseppe Ciaramella
President
2 sales
Apr 1, 2026
Christine Bellon
Chief Legal Officer
3 sales
Apr 1, 2026
Amy Simon
Chief Medical Officer
1 sale
Apr 1, 2026
Sravan Kumar Emany
Chief Financial Officer
1 sale
Dec 31, 2025
About FMR LLC's insider trades
FMR LLC is an insider at Beam Therapeutics (BEAM). Since Jul 6, 2009, it has reported 13 open-market purchases worth $29.1M and 113 sales worth $198.5M on SEC Form 4. In the last 12 months: 1 sale ($10.0M).
Its filings also include other transactions (35 filings), conversions (28 filings), gifts (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BEAM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.